Julie Yoo, Andreessen Horowitz general partner
October 5, 2023 10:09 AM EDT
Health Tech

Why An­dreessen Horow­itz's Julie Yoo sees AI as a 'leapfrog op­por­tu­ni­ty' for health­care

Lydia Ramsey Pflanzer

Deputy Editor

The Sil­i­con Val­ley ven­ture firm An­dreessen Horowitz in re­cent years has been in­vest­ing heav­i­ly in health­care and biotech, guid­ed by its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

For­mer FDA chief calls job cuts ‘hap­haz­ard, poor­ly thought-out’

No­vo looks to re­coup $830M from hy­per­ten­sion drug part­ner, claim­ing fraud

NIH pay­ment cuts are 'rea­soned and ra­tio­nal,' gov­ern­ment says

Af­ter re­search piv­ot, Bio­gen beefs up pipeline with Stoke's late-stage Dravet can­di­date

Ar­cus touts ear­ly kid­ney can­cer da­ta as Gilead de­clines op­tion

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times